FDAnews
www.fdanews.com/articles/195623-vivalnk-wearable-ecg-sensor-platform-cleared
VivaLNK Logo

VivaLNK Wearable ECG Sensor Platform Cleared

January 24, 2020

VivaLNK received FDA clearance for its Continuous ECG Platform that includes reusable wearable ECG sensors and a software development kit that gives  developers and providers direct control over data.

Application developers can use the VivaLNK platform to send sensor data directly to the application. The sensor does not collect personally identifiable information.

The software development kit also integrates with the previously FDA cleared and CE Marked VivaLNK temperature sensor, so multiple vitals to be remotely monitored from a single platform.

View today's stories